Aurinia Pharmaceuticals (AUPH) Net Cash Flow (QoQ) (2020 - 2026)
Aurinia Pharmaceuticals (AUPH) Net Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Aurinia Pharmaceuticals | 2.02 Bn | 1.64 Bn | 71.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -658.16% |
| Dec 31, 2025 | -65.21% |
| Sep 30, 2025 | 250.36% |
| Jun 30, 2025 | 21.05% |
| Mar 31, 2025 | -136.74% |
| Dec 31, 2024 | 1,139.38% |
| Sep 30, 2024 | 112.03% |
| Jun 30, 2024 | -299.26% |
| Mar 31, 2024 | 528.89% |
| Dec 31, 2023 | 107.02% |
| Sep 30, 2023 | -384.10% |
| Jun 30, 2023 | -41.06% |
| Mar 31, 2023 | -163.68% |
| Dec 31, 2022 | 112.38% |
| Sep 30, 2022 | -443.53% |
| Jun 30, 2022 | 119.21% |
| Mar 31, 2022 | -157.00% |
| Dec 31, 2021 | 372.47% |
| Sep 30, 2021 | -82.63% |
| Jun 30, 2021 | 69.74% |